@worldpdcongress.bsky.socialSara Whittingham—United States Air Force Veteran, physician, triathlete, mom, and person living with #Parkinsons — shared her book, Oh Crap! It’s Parkinson’s: A Rebel’s Guide to Taking Back Control of Your Life, at #WPC2026 in Phoenix this past May.
@britishneuro.bsky.socialProfessor Madeleine Lowery from @ucddublin.bsky.social
will open #BNA2027 with her plenary:
“Next Generation #DeepBrainStimulation for #Parkinsons Disease: Modelling, Neural Dynamics and Closed-loop Control”
🤝 Supported by @neuroscienceirl.bsky.social
@asapresearch.parkinsonsroadmap.orgThis month’s Discover ASAP features Nolwazi Gcwensa, MSc, PhD, on SynDOVE, an accessible protocol for studying synaptic proteins in 3D using confocal microscopy. 🔬
The approach can reveal changes that 2D analysis may miss, offering new insights into #Parkinsons.
📺 Watch: bit.ly/4z5OvuP
@longevitytech.bsky.socialLW-1017, an oral drug that switches the brain’s cleanup system back on, reduced Parkinson’s and Alzheimer’s pathology in aged mouse models.
Link as first comment.
@worldpdcongress.bsky.social🎙️ Happy #InternationalPodcastDay! Hear, Here Parkinson’s Podcast returns in 2027 with new co-hosts & stories. 🎧 Catch up on past episodes: worldpdcoalition.org/podcasts and listen on most streaming services.
@parkinsonseurope.bsky.social👉 It's a fantastic, inspiring interview, which you can read here: buff.ly/NxNqVoS
#Parkinsons #Parkinson #ParkinsonsArt #MiniaturePhotography #SabineLowenthal
@scienceofpd.bsky.socialApplicants must be either a PhD student or be in post-doctoral training in the UK or Europe, working directly on a project related to disease-modification in #Parkinsons
4 meetings per year (& the last one is in person, with a nice dinner afterwards!)
@scienceofpd.bsky.social"AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in #Parkinsons" - "The new FDA nod rounds out AbbVie’s broader portfolio by helping patients “through their entire Parkinson’s disease journey”"
www.fiercepharma.com/pharma/abbvi...
@neurologyacademy.bsky.socialWhat is #Parkinsons? Dr Lara Teare set the scene this morning at our PD Foundation MasterClass, covering epidemiology, genetics, anatomy and pathology.
@magnesnushu.bsky.social"For me, it was a miracle." Rob Warner shares how NUSHU improved his Parkinson's mobility. ▶️ Watch now! #Parkinsons #ParkinsonsDisease #Gait #Mobility #Neurorehabilitation #NUSHU #DigitalHealth #MedTech
@neurologyacademy.bsky.socialToday and tomorrow, we’re delighted to be hosting #Parkinsons Foundation MasterClass 51. Dr Tom Mace welcomed our delegates joining us in Sheffield and virtually. #ParkinsonsMC
@worldpdcongress.bsky.social🥗🧠 Can what we eat influence Parkinson’s? Explore the gut-brain connection in our latest #WPCBlog post by researcher Felipe Andrés Grunenwald Bravo, PhD.
🔗 Read the blog: https://ow.ly/KRUS50ZSuvb
Blog made with support from Supernus Pharmaceuticals.
@dotee2025.bsky.socialI have donated my brain to #parkinsons uk for research
@worldpdcongress.bsky.socialA powerful celebration of movement at #WPC2026 💙
Knots and Threads, choreographed by Pamela Quinn, brought the Opening Ceremony to life through movement —celebrating connection, resilience, and the many threads that bring the #Parkinsons community together.
@ret65.bsky.socialOne in six Parkinson's patients suffer complications during a hospital stay. The biggest expense families face is rarely medication. It is the cost of maintaining independence.
Eleanor O'Sullivan reports for Rethinking65 on what advisors and families need to know.
@wentyscihealth.bsky.social
@togetherforsharon.bsky.social🎬 IT’S LIVE! 🎬
Today, on my mother Sharon’s birthday, I’m sharing Sharon’s Story: Parkinson’s, Advocacy & Family.
Please watch, share & help us reach as many people as possible.
#Parkinsons #ParkinsonsAwareness #SharonStory #TogetherForSharon
@neurologylive.bsky.social🚨 BRREAKING: The #FDA has approved tavapadon (Juvmo; AbbVie), a once-daily oral selective D1/D5 dopamine receptor partial agonist for adults with Parkinson disease.
🇺🇸 AbbVie expects US availability in October 2026. Read more: www.neurologylive.com/view/fda-app...
#Parkinsons #Neurology
@nsrhighlights.bsky.socialIn a brainstem-seeded mouse model, REM-sleep abnormalities appeared before motor deficits and dopamine-neuron loss.
https://doi.org/10.1016/j.neures.2026.105023
#NeuroscienceResearch #Neuroscience #Parkinsons
@nsrhighlights.bsky.social運動障害が現れる前に、睡眠の異常を捉えられるでしょうか。変異型αシヌクレイン線維を脳幹へ入れたマウスでは、REM睡眠中の異常が先に現れ、その後に運動障害とドーパミン神経の減少が続きました。
https://doi.org/10.1016/j.neures.2026.105023
#NeuroscienceResearch #Neuroscience #Parkinsons